CHIR99021
- 3 independent labs in 3 countries
- 1 finding against
- Funders: National Research Foundation of Korea and 4 more
- Animals2
- Cells1
Outcomes
3Cellular senescence
downin cells1upin human cells1
2 studies
Cellular senescence
downin cells1upin human cells1
CHIR99021 induces cellular senescence in human cells.
“Although GSK3β inhibitor-mediated expansion increased hiPSC-CM yield, it induced telomere shortening, elevated DNA damage, and upregulation of senescence-associated markers”
Cellsin vitro expansion of hiPSC-CMs
Senescence modulated cardiac repair with pluripotent stem cell-derived cardiomyocytes
Stem cell research & therapy10 Jun 2026
CHIR99021 decreases cellular senescence in cells (no senescence dye uptake at all).
“Senescence assays after CHIR 99021 treatment also revealed no senescence dye uptake at all.”
Cellslate-passage MSCs
Inhibition of GSK-3β Restores Differentiation Potential of Late-Passage Mesenchymal Stem Cells
Pharmaceuticals (Basel, Switzerland)28 Mar 2025
Cell death
downin mice1
1 study
Cell death
downin mice1
CHIR99021 decreases cell death in mice.
“CHIR99021 mitigated RGC loss”
Animalsintravitreal injection in COH mice
Investigative ophthalmology & visual science2 Jun 2025
Tri-lineage differentiation potential
upin cells1
1 study
Tri-lineage differentiation potential
upin cells1
CHIR99021 improves tri-lineage differentiation potential in cells.
“CHIR 99021 reversed the differentiation inhibitory potential-mediated impasse of late-passage MSCs”
Cellslate-passage MSCs (>P15)
Inhibition of GSK-3β Restores Differentiation Potential of Late-Passage Mesenchymal Stem Cells
Pharmaceuticals (Basel, Switzerland)28 Mar 2025